Las Vegas, NV -- (SBWIRE) -- 01/07/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: Micromem Technologies Inc.(OTCBB:MMTIF), CYNAPSUS THERAPEUTIC(OTCMKTS:CYNAF), Affymax, Inc.(OTCMKTS:AFFY), Quadrant 4 Systems Corp(OTCMKTS:QFOR).
Micromem Technologies Inc.(OTCBB:MMTIF) ended lower -24.77% and complete the day at $0.820. The total number of shares changed hands during the day was 698,078. After opening at $0.96, the stock hit as high as $1.02. However, it traded between $0.15 and $1.74 over the last twelve months. Micromem Technologies Inc. (Micromem) is a development-stage company. The Company is engaged in the development of memory technology that has the characteristics of non-volatility, which is the ability to retain information after power has been shut off.
Has MMTIF Found The Bottom and Ready To Move Up? Find Out Here
CYNAPSUS THERAPEUTIC(OTCMKTS:CYNAF) closed yesterday at $0.927, a 24.14% increase. Around 524,355 shares were traded, beating an-average trading volume of 74,710 shares. The company is now valued at around $29.05 million. Cynapsus Therapeutics Inc., a specialty pharmaceutical company, is engaged in developing non-injectable drugs used to treat the symptoms of Parkinson?s disease. Its lead drug candidate includes APL-130277, an easy-to-administer, fast-acting, and oral reformulation of an approved drug, such as apomorphine, an injection that is used to rescue patients from OFF episodes.
For How Long CYNAF Gloss will Attract Investors? Find out via this report
Affymax, Inc.(OTCMKTS:AFFY) moved -7.35 percent lower at $0.945 and traded between $0.92 and $1.17 after opening the day at $1.04. Its performance over the last five days remained 18.2%, which stands at 7.39% for a month. Going back further than one month, 1-year performance after recent close was 21.15%.Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis.
Why Should Investors Buy AFFY After the Recent Fall? Just Go Here and Find Out
Quadrant 4 Systems Corp(OTCMKTS:QFOR) shares rose, gaining +10.85 percent to close at $0.950. The stock is down around -5% this year and 660% for the last 12 months. Around 119,698 shares changed hands yesterday, lower from an-average trading volume of 380,925 shares. Quandrant4 Systems Corp., formerly Zolon Corporation, is focused in the information technology (IT) sector as a provider of Software as a Service (SaaS) based technology products to enterprise customers in addition to custom software development, life cycle maintenance, outsourcing and consulting services.
Why Should Investors Buy QFOR After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)